The "Elevate" by MAPS Podcast

MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.

Working in rare disease offers Medical Affairs professionals the opportunity to engage directly with patient organizations and researchers/HCPs deeply involved in providing new options for patients who lack current treatments. However, working in rare disease also comes with significant challenges. Here MAPS sits down at our 2022 Global Annual Meeting with Catherine Parham, Vice President and Head of Global Medical Affairs at Astellas Gene Therapies to talk about the unique position of Medical Affairs in the rare disease space — and how our work in this area is essential for patient benefit.

Previous podcasts explore best practices for expert engagement, but MAPS Partner Circle member, H1, is in a unique position to notice patterns in the ways organizations struggle or simply fail to engage and support external experts. This episode of the Elevate podcast series details 4 things Field Medical teams can do better.

On this episode of the Medical Affairs Professional Society podcast series, "Elevate", we’re speaking about Health Equity with Ariel Katz, CEO of H1. Today, we'll be addressing what the role of Medical Affairs is in creating health equity, whether Medical Affairs is able to promote health equity in ways it couldn’t previously – or if Medical Affairs’ evolving role in health equity due more to increased awareness.

In this episode of the Medical Affairs Professional Society podcast series, "Elevate", we speak about embedding communications in Real-World Evidence strategy with Becky Galbraith, Senior Director, IQVIA Medical and Patient Communications and Barbara Arone, VP Medical Affairs Offerings, IQVIA. Specifically, we explore the necessity to consider communication as an essential element in the planning process for RWE studies. To learn more about how your organization can partner with IQVIA to discover and engage hidden thought leaders, visit Iqvia.com.

Medical Affairs is becoming more comfortable with the mechanics of digital listening to survey opinion and knowledge beyond our usual audiences. In this podcast we discuss two important categories of Digital Opinion Leaders (DOLs) we should all be listening to: Content Disseminators and Content Generators. According to our guest, Scott Thompson, Co-Chief Executive Officer at Acceleration Point, disseminators may help Medical Affairs spread knowledge, whereas generators may be important sources of insights. Check out this episode of the MAPS podcast series, "Elevate" to learn more.

Without the help of technology, transforming the output from engagement sessions into actionable insights can be a barrier to fast and precise decision-making. In this episode of the MAPS Elevate podcast series sponsored by Within3, you’ll learn how emerging technology can help Medical Affairs teams quickly understand the results of their engagements. Experts will demonstrate how to implement AI-powered natural language processing to gather, interpret and integrate insights to uncover the story in your data.

In this episode of the Medical Affairs Professional Society's Elevate Podcast series, we speak with presenters of the MAPS 2022 Global Annual Meeting session, “Developing and Executing and Integrated Medical Communications Strategy and Plan.” Topic covered include the planning basics, the evolution of the MedComms planning process, and new considerations for planning. Download the related white paper below. And we hope you will join this session Wednesday, March 23 at 11:30 at the MAPS Global Annual Meeting in New Orleans!

The second podcast of this two-podcast series continues our discussion on this critically important topic and discusses practical tips on how to incorporate cybersecurity into your own practices and devices. The Objectives for this podcast are to understand:What is the legal basis for cybersecurity expectations?What are some of the right questions to ask to ensure user health and safety is not compromised?What should be considered if a device has a measuring function, or if it is connected to the energy source?What needs to be included in this new era of risk, and what are some good examples and common pitfalls related to medical device risk management?

Join presenters of the MAPS 2022 Global Annual Meeting session "The Great Debate: How Medical Affairs can best support internal and external collaborations in patient engagement," as they detail the unique role of Medical Affairs in patient engagement. What can be done to ensure the patient voice is not only included, but also applied cross-functionally? How are patients getting more involved with pharmaceutical companies? What aspects of patient engagement with the pharmaceutical industry could be improved? Preview these topics now and then join the discussion at the MAPS 2022 Global Annual Meeting in New Orleans, March 20-23.